





















dAdditive Prognostic Value of Coronary Flow Reserve in Patients
With Chest Pain Syndrome and Normal or Near-Normal
Coronary Arteries
Rosa Sicari, MD, PhDa,*, Fausto Rigo, MDb, Lauro Cortigiani, MDc, Sonia Gherardi, MDd,
Maurizio Galderisi, MDe, and Eugenio Picano, MD, PhDa
In patients with angiographically normal coronary arteries and chest pain, pharmacologic
stress echocardiography can identify a subgroup of patients with a less benign prognosis.
Coronary flow reserve (CFR) in the left anterior descending artery (LAD) can currently be
combined with wall motion analysis during vasodilator stress echocardiography. The aim
of this study was to assess the prognostic value of CFR response in patients with normal
coronary arteries and normal wall motion during stress. We selected 394 patients (171 men,
61  11 years of age) who underwent dipyridamole stress echocardiography (0.84 mg/kg
over 6 minutes) with 2-dimensional echocardiography and CFR evaluation of the LAD by
Doppler. All had angiographically nonsignificant (<50% quantitatively assessed) stenosis
in any major vessel, normal left ventricular function (wall motion score index 1), and test
negativity for conventional wall motion criteria. Images were independently read by a core
laboratory for wall motion and a core laboratory for CFR. Mean CFR was 2.5  0.6 and
87 patients (22%) had an abnormal CFR <2. During a median follow-up of 51 months, 31
events occurred, namely 4 deaths and 27 nonfatal myocardial infarctions (3 ST-elevated
myocardial infarctions and 24 non–ST-elevated myocardial infarctions). Kaplan-Meier
survival estimates for hard events showed a better outcome for those patients with a normal
CFR compared with those with an abnormal CFR (96% vs 55%, p  0.001, at 48 months
of follow-up). In conclusion, in patients with angiographically normal or near-normal
coronary arteries and preserved at-rest regional and global left ventricular function at
baseline and during stress, CFR adds incremental value to the prognostic stratification























sIt has been demonstrated that, in patients with angiographi-
ally normal coronary arteries and chest pain, pharmaco-
ogic stress echocardiography can identify a subgroup of
atients with a less benign prognosis.1 Coronary flow re-
erve (CFR) evaluated by pulse Doppler echocardiography
ssociated with vasodilatory stress has recently entered the
tress echocardiographic laboratory.2–5 The combination of
onventional, wall motion analysis with 2-dimensional
chocardiography and CFR with pulse Doppler flowmetry
f the mid-distal left anterior descending artery (LAD) has
een proved to provide an additive and complementary
ower of prognostication in patients with known or sus-
ected coronary artery disease (CAD).6,7 A decreased CFR
s an additional parameter of severity of ischemia in the risk
tratification of the stress echocardiographic response,7
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oi:10.1016/j.amjcard.2008.10.033hereas patients with a negative test result for wall motion
riteria and normal CFR have a favorable outcome during
ipyridamole stress echocardiography.6 CFR provides inde-
endent prognostic information also in diabetic and nondi-
betic patients with known or suspected CAD and negative
ipyridamole stress echocardiographic result for wall mo-
ion criteria.8 The aim of the present study was to assess the
rognostic value of CFR response in patients with normal
oronary arteries and normal wall motion during stress.
ethods
From the Echo Persantine International Cooperative Study
EPIC) databank from 2002 to 2007, 610 patients were
elected according to the following criteria: history of chest
ain, dipyridamole echocardiographic test (0.84 mg/kg over
minutes) performed before (within 15 days) coronary
ngiography, and coronary angiogram showing absent or
onsignificant (50% quantitatively assessed) stenosis in
ny major vessel or secondary branch. Of this initial popu-
ation, 216 patients were excluded because 82 underwent a
revious revascularization, 99 had a wall motion score in-
ex1, 29 had a positive test result for wall motion criteria,
nd 6 were lost to follow-up. Thus, the study group con-
isted of 394 patients (171 men, mean age 61  11 years).





















































































































627Coronary Artery Disease/CFR and Normal Coronary Arteriesatients were evaluated after antianginal drugs had been
iscontinued and 173 patients were evaluated during antian-
inal treatment (nitrates and/or calcium antagonists and/or
blockers). The subset of patients on -blocking agents used
he highest tolerated dose of metoprolol or atenolol. Coro-
ary angiography and dipyridamole stress echocardiogra-
hy were separately and independently performed and an-
lyzed by cardiologists unaware of the results of the other
ests. Stress echocardiographic data were collected and an-
lyzed by stress echocardiographers not involved in patient
are.
Data are entered into the databank at the time of testing
n the same day of test performance. Follow-up information
n outcome is updated by a dedicated team of technicians
upervised by physicians not involved in patient care. Phy-
icians responsible for updating the follow-up information
ere unaware of stress echocardiographic and coronary
ngiographic data. The study was approved by the institu-
ional review board. All patients gave their written informed
onsent when they underwent stress echocardiography and
oronary angiography. The decision to perform coronary
ngiography in the face of a negative stress echocardio-
raphic test result was taken by the referral physicians on
he basis of the clinical picture. All patients were fol-
owed-up for a median of 51 months (first quartile 27, third
uartile 74) with a minimum predefined follow-up time of 3
onths.
Transthoracic stress echocardiographic studies were per-
ormed with commercially available ultrasound machines
Sonos 7500, and ie33, Philips Ultrasound, Andover, Mas-
achusetts; Sequoia C256, Acuson Siemens, Mountain
iew, California; Vivid System 7, GE/Vingmed, Milwau-
ee, Wisconsin) equipped with multifrequency phased-ar-
ay sector scan probes (S3 to S8 or V3 to V7) and with
econd harmonic technology. All standard echocardio-
raphic views were obtained when possible, i.e., parasternal
ong- and short-axis, apical 2-, 3-, and 4-chamber, and
ubsternal views. In addition to classic projections for stress
chocardiographic testing, specific projection for LAD im-
ging is integrated into the cardiac imaging sequence. Two-
imensional echocardiography and 12-lead electrocardio-
raphic monitoring were performed in combination with
igh-dose dipyridamole (up to 0.84 mg over 6 minutes) in
ccordance to a well-established protocol, with no atropine
oadministration.9 During the procedure, blood pressure
nd electrocardiogram were recorded each minute. The left
entricle was divided into 17 segments as suggested by the
uropean Association of Echocardiography.9 Segmental
all motion was graded as 1 when normal, 2 when hypo-
inetic, 3 when akinetic, and 4 when dyskinetic. Wall mo-
ion score index was derived by dividing the sum of indi-
idual visualized segment scores by the number of
isualized segments.9
CFR was performed during the standard stress echocar-
iographic examination by a semi-simultaneous imaging of
all motion and LAD flow.9 Coronary flow in the mid-
istal portion of the LAD was searched in a low parasternal
ong-axis cross section under the guidance of color Doppler
ow mapping.9 If no color-coded blood flow from the LAD
as visualized at the baseline condition, the procedure wasttempted a second time during contrast enhancement with tonoVue (Bracco-Byk-Gulden, Konstanz, Germany) in a
olus (0.5 ml intravenously) in 125 patients (32% of total
opulation).
All studies were digitally stored to simplify offline re-
iewing and measurements. Coronary flow parameters were
nalyzed offline by use of the built-in calculation package of
he ultrasound unit. Flow velocities were measured 2
imes for each study: at baseline and at peak stress (before
minophylline injection). At each time point, 3 optimal
rofiles of peak diastolic Doppler flow velocities were mea-
ured, and the results were averaged. Coronary blood flow
elocity reserve was defined as the ratio between hyperemic
nd basal peak diastolic coronary flows. CFR was consid-
red normal when it was 2.7 All images digitally stored
ere independently read and reviewed by a core laboratory
or wall motion (Institute of Clinical Physiology, Pisa, Italy)
nd a core laboratory for CFR (Cardiology Division, Um-
erto I° Hospital, Mestre-Venice, Italy). All investigators
ere instructed to obtain all standard stress echocardio-
raphic projections for wall motion assessment and CFR
see earlier); images were digitally stored at rest, at peak
ipyridamole stress test, and after aminophylline infusion.9
igital images obtained were sent to the core laboratory
hrough the internet together with the investigator’s stress
chocardiographic report and measurements of CFR. Stress
chocardiographic quality control was performed as fol-
ows. A reader from each recruiting center met the pre-
efined criteria for stress echocardiographic reading. At that
oint, the center could start recruiting patients and reading
f stress echocardiograms from the recruiting center was
hen directly sent to the core laboratories.
Coronary angiography in multiple views was performed
ccording to standard Judkins and Sones techniques. At
east 5 views (including 2 orthogonal views) were acquired
or the left coronary arteries and 2 orthogonal views for
he right coronary arteries, respectively. Additional appro-
riate projections were obtained in case of superimposition
f side branches or foreshortening of the segment of inter-
st. All angiograms were visually evaluated by 2 indepen-
ent observers who identified stenotic segments and scored
ontrol arteries as smooth or irregular. All stenotic segments
ere evaluated by an automated edge-detection system (GE
ealthcare) providing percent stenosis diameter.
Follow-up data were obtained from 1 of 4 sources:
eview of a patient’s hospital record, personal communica-
ion with a patient’s physician and review of a patient’s
hart, a telephone interview with a patient conducted by
rained personnel, and/or a staff physician visiting a patient
t regular intervals in the outpatient clinic. According to
tudy protocol follow-up information was obtained every 3
onths. Events were defined as death or nonfatal acute
oronary syndromes. In patients who died in the hospital or
t home, cause of death was elucidated from the medical
ecord, the family, and the local physician who signed the
eath certificate. The definition of cardiac death required
ocumentation of significant arrhythmias and/or cardiac ar-
est or death attributable to congestive heart failure or myo-
ardial infarction in the absence of any other precipitating
actors. In case of deaths out of hospital for which no
utopsy was performed, sudden unexpected death was at-





























































































628 The American Journal of Cardiology (www.AJConline.org)ause of death,10 overall mortality was considered. The
efinition of nonfatal acute coronary syndromes included
T-elevation myocardial infarction (STEMI) or non-STEMI
NSTEMI). STEMI was defined by typical symptoms, ST
levation on electrocardiogram, and cardiac enzyme
hanges. NSTEMI was an acute coronary syndrome causing
ypical chest pain, cardiac enzyme increase, and/or electro-
ardiographic modifications consistent with acute isch-
mia11 requiring hospitalization. Follow-up data were ana-
yzed for prediction of death, STEMI, or NSTEMI.
Therefore the outcome events were all-cause death (de-
ned as cardiac and noncardiac death) for survival and hard
vents (death and nonfatal MI [STEMI or NSTEMI]) for
nfarction-free survival. When 1 of these events occurred,
he patient was censored at the time of the most severe
vent.
Statistical analyses included descriptive statistics (fre-
uency and percentage for categorical variables and mean 
D for continuous variables) and Kaplan-Meier survival
urves. The individual effect of certain variables on event-
ree survival was evaluated with the use of a Cox regression
odel. The individual effect of a certain variable on event-
ree survival was evaluated with the use of a Cox regression
odel (SPSS, SPSS, Inc., Chicago, Illinois; S-plus 6.1, Palo
lto, California). Analysis was performed according to the
nmodified backward selection stepwise procedure. Propor-
ional hazards assumptions of the Cox model were verified
ith a linear correlation test. A statistical significance of
.05 was required for a variable to be included into the
ultivariable model, whereas 0.1 was the cut-off value for
xclusion. Hazard ratios (HRs) with corresponding 95%
onfidence intervals (CIs) were estimated.
The following covariates were analyzed: age, gender,
moking, typical chest pain, hypertension, diabetes, hyper-
holesterolemia, electrocardiographic modifications during
ipyridamole stress testing, presence of angina during di-
yridamole stress, CFR in the LAD, and presence of vessel
rregularities on coronary angiogram. Differences in sur-
ival rates between groups were tested by log-rank test. All
nalyses were performed using SPSS 13.0 (SPSS, Inc.); all
ests were 2-sided and a p value 0.05 was considered
able 1
t-rest and stress findings in study population
ariable CFR 2 CFR 2 p Value
(n  307) (n  87)
ge (yrs) 60  11 65  9 0.000
en/women 139/168 32/55 NS
moking habit 98 (32%) 22 (25%) NS
ypertension 176 (57%) 62 (71%) 0.025
iabetes 55 (18%) 14 (16%) NS
eft bundle branch block 16 (5%) 4 (5%) NS
jection fraction (%) 59  5 59 5 NS
FR in LAD 2.7  0.5 1.8  0.1 0.000
est performed during antianginal
therapy
122 (40%) 51 (59%) 0.002
-blocking agents 73 (24%) 34 (39%) 0.006
Calcium antagonists 69 (22%) 27 (31%) NS
Long-acting nitrates 25 (8%) 14 (16%) 0.04tatistically significant. aesults
The main clinical and echocardiographic data are presented
n Table 1.
By selection all patients had a normal regional and global
eft ventricular function (wall motion score index 1). Mean
FR value was 2.5  0.6. At individual patient analysis,
07 patients had normal CFR (2.0) and 87 had abnormal
FR in the LAD. Of the 87 patients with abnormal CFR, 51
ere under anti-ischemic medical therapy (59%) as were
22 (40%) of those with normal CFR. Patients with abnor-
al CFR had a higher incidence of arterial hypertension
71% vs 57%, p  0.025). CFR was significantly lower in
atients with left ventricular hypertrophy compared with
hose without (2.6  0.6 vs 2.3  0.4, p 0.001). Left
entricular mass index was not a significant parameter when
ntered in the Cox model (HR 0.9, 95% CI 0.9 to 1.0, p 
.4).
All patients had “nonsignificant” CAD by selection.
owever, 282 patients had completely normal, smooth cor-
nary arteries; 28 had “mild” (0% to 20% diameter stenosis,
ean 19  2.6) irregularities of 1 vessel; 76 had “mod-
rate” (20% to 40% diameter stenosis, mean 34  5) irreg-
larities. CFR was normal in 229 of 282 patients (81%) with
otally normal coronary arteries and in 78 of 112 (69%) with
ear-normal coronary arteries (showing 1 of the previ-
usly described abnormalities). Mean CFRs in the LAD
ere 2.6  0.6 in subjects with normal coronary arteries,
.6 0.6 in subjects with mild abnormalities, and 2.2 0.5
n subjects with moderate abnormalities (p  0.000, normal
oronary arteries vs mild and vs moderate abnormalities).
atients with coronary irregularities were older (65  10 vs
9  12 years, p  0.005) than patients with completely
ormal coronary arteries and smoking habit was signifi-
antly greater (40% vs 26%, p  0.011).
During a median follow-up of 51 months (first quartile
7, third quartile 74), a total of 31 (7.8%) events (4 deaths
nd 27 nonfatal MIs [3 STEMIs and 24 NSTEMIs]) oc-
urred. Considering hard events, there were 6 events in
atients with normal CFR versus 25 events in patients with
igure 1. Kaplan-Meier survival curves (considering hard cardiac events as
n end point) in patients stratified according to normal (2) or abnormal
2) CFR at Doppler echocardiography during dipyridamole stress echo-
ardiography. Survival rate with a CFR 2 is significantly different from
hat with a CFR2 (p0.0001). Best survival is observed in patients with

















































































i is not s
629Coronary Artery Disease/CFR and Normal Coronary Arteriesoronary irregularities in the LAD did not have a signifi-
antly higher event rate than patients with irregularities in
nother territory (9% vs 7.5%, p  0.6). Univariable pre-
ictors of hard events were hypertension (HR 2.9, 95% CI
.2 to 7.2) and abnormal CFR (HR 16.7, 95% CI 6.7 to
0.2). Using the Cox proportional hazards model including
clinically significant parameters (age, gender, cardiovas-
ular risk factors, left ventricular MI, coronary irregularities
t angiography, and aspirin use), only hypertension was an
ndependent predictor of outcome (HR 3.4, 95% CI 1.3 to
.7); when CFR was included in the model, it remained the
ole independent predictor of hard events (HR 16.4, 95% CI
.7 to 40.2). Kaplan-Meier survival estimates for hard
vents showed a better outcome for those patients with
ormal CFR compared with those with abnormal CFR (96%
s 55%, p  0.001, at 48 months of follow-up; Figure 1).
aplan-Meier survival estimates for hard events showed no
ifference of outcome in patients with normal coronary
rteries compared with those with irregularities (84% vs
7%, p  0.4, at 48 months of follow-up; Figure 2).
iscussion
In patients with angiographically normal or near-normal
oronary arteries and preserved at-rest regional and global
eft ventricular function at baseline and during stress, CFR
dds incremental value to the prognostic stratification
chieved with clinical and angiographic data.
In the absence of CAD, CFR can be decreased in micro-
ascular disease (e.g., in syndrome X, arterial hypertension,
iabetes, and/or left ventricular hypertrophy),12,13 which
ay per se decrease CFR independently of microvascular
amage.14–16 In this condition, angina with ST-segment
epression can occur with regional perfusion changes, typ-
cally in the absence of any regional wall motion abnormal-
ties during stress.17–20 Milder forms of decrease in regional
FR and/or abnormal coronary microcirculatory function
ay occur in patients with angiographically normal coro-
ary arteries and may give rise to a positive perfusion scan
esult14–16 or to a strictly subendocardial decreased perfu-
ion14 of limited extent to decrease regional CFR but not
evere enough and/or transmurally extended to give rise to
igure 2. Kaplan-Meier survival curves (considering hard cardiac events a
rregularities at coronary angiography. Survival rate with normal arteriesransient wall motion abnormalities.17,20 In more advanced legrees of decrease in CFR, subendocardial underperfusion
bove the threshold necessary to reach a critical ischemic
ass may evoke transient dyssynergy, the prerequisite of
tress echocardiographic positivity by wall motion criteria.
he latter is not the case for the present study in which, by
election, only patients with negative stress echocardiogram
y wall motion criteria were investigated.
It is considered that chest pain with the angiographic
abel of “normal coronary arteries” readily identifies a prog-
ostically benign subset.21,22 However, there can be sub-
tantial morphologic heterogeneity within this cohort, en-
ompassing truly normal, smooth coronary arteries and
onsignificant stenoses, which may be mild or moderate,
solated or multiple, in 1 vessel. Another important an-
iographic sign can be coronary calcification, which is
nown to be associated with more extensive coronary ath-
rosclerosis and worse prognosis.23 In fact, the subset of
atients with minor abnormalities had a lower value of CFR.
n a study by Zimmerman et al24 no significant difference
as found in survival rates in patients with normal arteries
nd minimal or moderate disease, but the reinfarction rate
as higher in those with minimal and moderate disease
11% and 16%, respectively, p  0.0002) than in patients
ith angiographically normal arteries. Two recent meta-
nalyses21,22 have shown that patients with chest pain and
ormal or nonobstructive angiograms are predominantly
omen, and many have a prognosis that is not as benign as
ommonly thought; this applies also to patients with non–
T-segment elevation acute coronary syndromes with non-
bstructive CAD detected by angiography who have a sub-
tantial risk of subsequent coronary events within 1 year.
e demonstrated in a previous study1 that pharmacologic
tress echocardiographic positivity in patients with chest
ain and angiographically normal or near-normal coronary
rteries is associated with a worse long-term survival. The
anatomic lies” of stress echocardiography, i.e., false posi-
ive responses occurring in patients with nonsignificant epi-
ardial CAD, can be overturned into “prognostic truth”
hen long-term outcome is considered. CFR assessed by
ntracoronary Doppler in normal to mildly diseased arteries
as been demonstrated to be an independent predictor of
point) in patients stratified according to normal coronary arteries or with




























































630 The American Journal of Cardiology (www.AJConline.org)ients in the lowest tertile of CFR had a cardiovascular
vent. CFR in the LAD provides additional prognostic value
ver stress echocardiographic results in patients with known
r suspected CAD6,7 and allows effective risk stratification
n different clinical settings, including diabetic patients with
egative stress echocardiogram by wall motion criteria.26 In
act, regional wall motion and CFR provided additive, not
edundant, prognostic information. Indeed, coronary endo-
helial dysfunction, left ventricular hypertrophy, and coro-
ary microcirculatory dysfunction do not normally induce
all motion abnormalities but have been linked to adverse
utcome.27
CFR was sampled only in the LAD. There is no doubt
hat the 3-coronary approach would be more fruitful, but
urrently it remains too technically challenging for a large-
cale assessment. It has been demonstrated with several
echniques that microcirculatory dysfunction affects the left
entricle globally and regionally,28 and therefore CFR as-
essment in the LAD, which would be inadequate for CAD
etection, is an excellent option for evaluating global cor-
nary microcirculation conditions in these patients. Doppler
ssessment of CFR has some limitations. Assessment of
bsolute blood velocity can be limited in some patients by
he large incident angle between the Doppler beam and
lood flow. However, calculation of flow reserve allows
ssessment of flow patterns without the need for absolute
alues. More importantly, velocity ratio is used as a surro-
ate of flow reserve: flow within the coronary artery is not
alculated because cross-sectional visualization of the ves-
el does not allow accurate measurement of the diameter of
he vessel. Estimated flow reserve can be accurate if the
oronary functions only as a conduit, without changing in
iameter during drug infusion. This assumption is reason-
ble with dipyridamole29,30 and less valid with dobutamine;
his is an additional reason to stress CFR with vasodilators.
ur study design was observational, not randomized, and
he analysis was retrospective, although the data were ac-
uired in a prospective fashion and entered into the data-
ank at the time of initial assessment. Selection criteria
ncluded all patients referred for stress echocardiography
ith subsequent documentation of normal coronary arteries
n the same hospital admission. This led to inclusion of
atients with different clinical conditions and heterogenous
ngiographic patterns.
Abnormal CFR in the LAD and test negativity for wall
otion criteria during vasodilator stress testing and normal
oronary arteries can identify a subgroup of patients with a
ess benign prognosis. It is conceivable that these higher-
isk patients should be treated more aggressively in terms of
ifestyle changes and risk-factor modifications.
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